Overall rank by patents
#45,491
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A47L (DOMESTIC WASHING OR CLEANING ; SUCTION CLEANERS IN GENERAL).
The verdict
CFS holds 5 US patents across 4 technology areas, rank #45,491 of 50,000 tracked assignees.
CFS Brands, Llc has been granted 5 US utility patents between 2018 and 2025, placing CFS Brands, Llc at rank #45,491 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.6 claims per patent with primary concentration in A47L (DOMESTIC WASHING OR CLEANING ; SUCTION CLEANERS IN GENERAL). As a US Corporation, CFS Brands, Llc is one of the more focused assignees in the PatentsView dataset. By volume, CFS sits between Cerno Bioscience Llc (5 patents, rank #45,487) and Cgenetech (suzhou, China) Co., Ltd. (5 patents, rank #45,495) - the closest US assignees by grant volume. The composite Innovation Score of 38.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 1 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. CFS Brands, Llc's 8.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CFS Brands, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CERNO BIOSCIENCE LLC
5 patents
CESCA THERAPEUTICS, INC.
5 patents
CESIUM AB
5 patents
CEVA ANIMAL HEALTH INC.
5 patents
CFT S.P.A.
5 patents
CG ONCOLOGY, INC.
5 patents
CGTech
5 patents
CGeneTech (Suzhou, China) CO., Ltd.
5 patents
CFS Brands, LLC
5 patents
What this shows CFS holds 5 patents at rank #45,491, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,491 in granted patent volume.
Other assignees with the most granted patents in CFS's primary technology class.
CFS's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2022 | 1 | 20.0% |
| 2024 | 2 | 40.0% |
| 2025 | 1 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#45,491
Across all tracked assignees
38.4 out of 100
How to use this portfolio
CFS's 5 grants land it in the top 41% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.